quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:30:29·42d
SECFiling
Harvard Bioscience Inc. logo

Harvard Bioscience Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

HBIO· Harvard Bioscience Inc.
Industrials
Original source

Companies

  • HBIO
    Harvard Bioscience Inc.
    Industrials

Recent analyst ratings

  • Apr 9UpdateKeyBanc Capital Markets-
  • Mar 10UpdateThe Benchmark Company$4.00

Related

  • SEC2d
    SEC Form DEFA14A filed by Harvard Bioscience Inc.
  • SEC2d
    SEC Form DEF 14A filed by Harvard Bioscience Inc.
  • INSIDER22d
    SEC Form 4 filed by Frost Mark T
  • INSIDER22d
    SEC Form 4 filed by Frost Mark T
  • INSIDER31d
    SEC Form 4 filed by Duke John D
  • INSIDER36d
    SEC Form 4 filed by Denelsky Stephen J
  • INSIDER36d
    SEC Form 4 filed by Snider William
  • INSIDER37d
    Chief Executive Officer Duke John D bought $25,050 worth of shares (5,000 units at $5.01), increasing direct ownership by 5% to 105,000 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022